期刊文献+

灭活卡介苗治疗婴幼儿哮喘的临床疗效观察 被引量:2

Clinical efficacy inactivated BCG inoculation in infants with asthma
原文传递
导出
摘要 目的探讨灭活卡介苗经皮接种治疗婴幼儿哮喘的临床疗效。方法选择2001-07—2003-03于湖南省人民医院就诊的85例年龄9个月至3岁的哮喘婴幼儿,应用随机数目表法将来院就诊的患儿分为治疗组45例(应用灭活卡介苗组)和对照组40例。观察治疗前后免疫球蛋白E(IgE)、嗜酸性阳离子蛋白(ECP)、白细胞介素-4(IL-4)、γ-干扰素(IFN-γ)、纯结核蛋白衍生物(PPD)试验、哮喘的发作程度的变化及疗效的评价。结果与对照组比较,治疗组患儿IL-4、IFN-γ,ECP、PPD的变化有统计学意义(P<0·05),哮喘发作程度、临床疗效差异也存在显著性意义(P<0·01),临床总有效率为86.67%。结论灭活卡介苗经皮接种有明显的治疗作用,可作为防治婴幼儿哮喘的有效方法之一。 Objective To investigate the clinical value inactivated bacillus Calmette-Guerin(BCG) inoculation in infants with asthma,and to explore the effect between the constant stimulation by inactivated BCG inoculation and the asthma episode, Methods Forty-five young children with asthma aging from 9 months to 3 years,were included in this study. Serum levels of IgE and ECP were determined with enzyme linked fluoroimmunoassay by Phamacia CAP system. The concentrations of IFN-γ, IL-4 from peripheral blood mononuclear cells( PBMC )were measured using ELISA before and after inactivated BCG inoculation. PPD, the degree of the asthma episode and the clinical effect were followed after therapy. Forty infants with asthma receiving the the routine treatment served as the controls. Results After inactivated BCG inoculation for 6 months,the IFN-γ levels increased significantly from 16. 36±7. 10pg/L to 241.59 ± 111.25pg/L( P 〈0. 01 ). The IL-4 and ECP levels decreased significantly from 214. 36 ± 90. 88pg/L, 13.40 ± 20. 21 μg/L to 46. 13 ± 21.46pg/L,5.51±6.46μg/L ( P 〈0.05) respectively( P 〈0.05). PPD positive transformation increased from 15.6% to 93.3% after treatment. The degree of the asthma episode and the clinical effect changed significantly. Conclusion Inactivated BCG treatment may have significant clinical effect. The vaccine therapy will be aviailable to children with asthma.
出处 《中国实用儿科杂志》 CSCD 北大核心 2006年第8期599-601,共3页 Chinese Journal of Practical Pediatrics
关键词 卡介苗 哮喘 治疗 婴幼儿 BCG Asthma Therapy Infants
  • 相关文献

参考文献9

二级参考文献50

  • 1王金荣,冯益真,孙中厚,戴铁成,杨金芝.哮喘患儿痰液ECP,IgE,IL-5和sIL-2R水平及其临床意义的研究[J].中国当代儿科杂志,1999,1(1):9-11. 被引量:1
  • 2Kim K.D, Lee HG, Kim JK, et al. Enhanced antigen-presenting activity and tumour necrosis fatter-alpha-independent activation of dendritic cells following treatment with Mycobacterium bovis Calmette-Guerin[J]. Immunology. 1999_97(4):626- 33.
  • 3Tascon RE, Soares CS, Ragno S, et al. Mycobacterium tubemalosis-activated dendritic cells induce protective immunity in mlce[J].Immunology, 2000,99(3):473-80.
  • 4Moser M, Murphy KM. Dendritic cell regluation of Th1-Th2 development[J]. Nat Immunol, 2000,1(3):199- 205.
  • 5Kalinski P, Hilkens CM, Wieaxnga EA, et al. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal[J].Immunol Today, 1999,20(12):561- 7.
  • 6Reid SD, Penna G, Adorini L. The eontrol of T cell responses by dendritic cell subsets[J]. Curr Opin Immunol, 2000,12(1):114-21.
  • 7Reider N, Reider D, Ebner S, et al. Dendritic cells contribute to the development of atopy by an insufficiency in IL- 12 production[J]. J Allergy Clin Immunol, 2002,109(1):89-95.
  • 8Goriely S, Vincart B, Stordeur P, et al. Deficient I1- 12 (p35) gene expression by dendritic cells derived from nonatal monocytes[J]. J Immunol, 2001,166(3):2141 - 6.
  • 9Shimkawa T, Enomoto T, Shimazu S, et al. The inveme assocation between tulmcttlin responses and atopic disorder[J]. Science, 1997,275(5296):77- 9.
  • 10Kon YI, Choii IS, Kim WY. BCG infection in allergen- presensitized rats suppresses Th2 immune respome and prevents the development of allergic asthmatic reaction[J]. J Clin Immunol, 2001,21(1);51-9.

共引文献2387

同被引文献23

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部